Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis.

Overview of attention for article published in JNCI: Journal of the National Cancer Institute, October 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

news: 1 news outlet
twitter: 10 X users

facebook: 3 Facebook pages

Readers on

mendeley: 113 Mendeley

Summary News X Facebook

So far, Altmetric has seen 2 news stories from 1 outlets.

Emerging Uses for Circulating Tumor Cell Technology

OncLive, 21 Aug 2023

Detection of circulating tumor cells (CTCs), which are released from primary or metastatic lesions into the bloodstream and are…

CTC Surveillance in Early-Stage Breast Cancer: What's Next?

OncLive, 14 Mar 2019

Joseph A. Sparano, MD Blood-based biomarkers great potential for use in the management of breast and other cancers.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.